Literature DB >> 10411426

Cimetidine therapy for recalcitrant warts in adults: is it any better than placebo?

C J Rogers1, M D Gibney, E C Siegfried, B R Harrison, D A Glaser.   

Abstract

Three open-label, uncontrolled studies have documented successful treatment of warts with cimetidine, whereas two placebo-controlled, double-blind studies and two open-label comparative trials have failed to demonstrate efficacy. This double-blind, placebo-controlled study was designed with stringent enrollment and outcome criteria to minimize the confounding issue of spontaneous remission. Efficacy was not statistically superior to that of placebo, but a trend toward efficacy was suggested for younger subjects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10411426     DOI: 10.1016/s0190-9622(99)70421-4

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  6 in total

Review 1.  Warts (non-genital).

Authors:  Steven King-Fan Loo; William Yuk-Ming Tang
Journal:  BMJ Clin Evid       Date:  2009-09-24

Review 2.  An armamentarium of wart treatments.

Authors:  Michelle M Lipke
Journal:  Clin Med Res       Date:  2006-12

Review 3.  Immunomodulators in warts: Unexplored or ineffective?

Authors:  Surabhi Sinha; Vineet Relhan; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2015 Mar-Apr       Impact factor: 1.494

Review 4.  Evolving role of immunotherapy in the treatment of refractory warts.

Authors:  Devinder M Thappa; Minu J Chiramel
Journal:  Indian Dermatol Online J       Date:  2016 Sep-Oct

5.  Immunotherapy with intralesional Candida albicans antigen in resistant or recurrent warts: a study.

Authors:  Imran Majid; Saher Imran
Journal:  Indian J Dermatol       Date:  2013-09       Impact factor: 1.494

6.  Cimetidine: A Safe Treatment Option for Cutaneous Warts in Pediatric Heart Transplant Recipients.

Authors:  Bibhuti B Das; Kristin Anton; Nelia Soares; Susan Riojas; Jodi Mcdermott; Leah Knox; Susan Daneman; Bao N Puente
Journal:  Med Sci (Basel)       Date:  2018-04-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.